Moderna Inc (MRNA)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -3,945,000 | -4,239,000 | 9,420,000 | 13,296,000 | -763,144 |
| Total assets | US$ in thousands | 14,142,000 | 18,426,000 | 25,858,000 | 24,669,000 | 7,337,000 |
| Operating ROA | -27.90% | -23.01% | 36.43% | 53.90% | -10.40% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $-3,945,000K ÷ $14,142,000K
= -27.90%
Analyzing the operating return on assets (operating ROA) of Moderna Inc provides insight into the company's operational efficiency in generating profits relative to its asset base.
In 2020, Moderna Inc reported a negative operating ROA of -10.40%, indicating that the company's operating income was insufficient to cover the asset base, possibly due to higher operating expenses or lower revenue generation.
By the end of 2021, Moderna Inc significantly improved its operational performance, achieving an impressive operating ROA of 53.90%. This substantial increase suggests that the company effectively utilized its assets to generate operating income, signaling operational efficiency and potential profitability.
In 2022, Moderna Inc maintained a strong operating ROA of 36.43%, indicating continued efficiency in generating profits from its assets. This stability suggests that the company's operational strategy remained effective in leveraging its asset base.
However, there was a notable decline in Moderna Inc's operating ROA by the end of 2023, dropping to -23.01%. This negative trend may signal challenges impacting the company's ability to generate profits from its assets, potentially due to increased operating costs or lower revenue.
Closing 2024, Moderna Inc experienced a further decrease in operating ROA, falling to -27.90%. This continued decline highlights operational inefficiencies and raises concerns about the company's asset utilization and profitability in the most recent period.
Overall, Moderna Inc's fluctuating operating ROA over the years reflects varying levels of operational efficiency and financial performance, emphasizing the importance of closely monitoring and addressing factors influencing the company's ability to generate returns from its assets.
Peer comparison
Dec 31, 2024